Sinomab Bioscience Ltd

This early-stage study tested a single dose of the SM17 antibody in 30 healthy Chinese adults to see if it is safe and how the body processes it. The goal was not to treat any disease, but to gather important safety and drug-level information. No direct benefit was expected for p…